Benecchi Christopher 4
4 · Sage Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Benecchi Christopher
Chief Operating Officer
Transactions
- Award
Common Stock
2025-04-10+3,255→ 47,170 total - Tax Payment
Common Stock
2025-04-10$6.91/sh−661$4,568→ 48,428 total - Award
Common Stock
2025-04-10+2,712→ 49,089 total - Tax Payment
Common Stock
2025-04-10$6.91/sh−793$5,480→ 46,377 total
Footnotes (2)
- [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 9,300 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 3,255 shares.
- [F2]On June 16, 2022, the reporting person was granted PSUs to acquire a total of 7,750 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 2,712 shares.